Skip to main content
. 2018 Sep 18;9:418. doi: 10.3389/fpsyt.2018.00418

Table 1.

Baseline characteristics of responders and non-responders to MBSR.

Characteristics Responders (n = 11)
Mean (S.D.) or n (%)
Non-responders (n = 11)
Mean (S.D.) or n (%)
Test statistic p-value
Age 60.4 (14.5)
range: 33–79
58.2 (10.2)
range: 40–69
t = 0.409, 20df 0.69
BMI 31.64 (4.178) 31.09 (7.816) t = 0.204, 20df 0.84
SEX
   Male 9 (82%) 9 (82%) X2 = 0.0, 1df 1.0
   Female 2 (18%) 2 (18%)
RACE
   White 11 (100%) 11 (100%) X2 = 0.0, 1df 1.0
SERVICE ERA
   OEF/OIF 2 (18%) 1 (9%) X2 = 2.41, 3df 0.49
   Gulf War 0 (0%) 2 (18%)
   Vietnam War 7 (64%) 6 (55%)
   Other 2 (18%) 2 (18%)
SERVICE DURATION
    <1 year 1 (9%) 1 (9%) X2 = 2.8, 3df 0.42
   1–2 years 4 (36%) 1 (9%)
   2–5 years 3 (27%) 6 (55%)
   >5 years 3 (27%) 3 (27%)
Any Childhood Trauma (Y/N) 4 (36%) 2 (18%) X2 = 0.92, 1df 0.34
Lifetime trauma (number events) 9.0 (3.2) 6.5 (3.2) t = 1.78, 20df 0.09
PCL Total Score 63.2 (7.3) 61.5 (14.3) t = 0.36, 20df 0.36
PCL Reexperiencing 17.73 (3.6) 17.64 (5.4) t = 0.047, 20df 0.96
PCL Avoidance 26.45 (3.01) 25.91 (5.5) t = 0.29, 20df 0.77
PCL Arousal 19.0 (4.2) 17.9 (4.9) t = 0.56, 20df 0.58
PHQ9 number of symptoms endorsed 13.5 (5.5) 15.3 (5.8) t = −0.71, 20df 0.48
Number of psychotropic medications 1.4 (0.5) 1.8 (0.9) t = −1.494, 20df 0.15
Antidepressant user 10 (91%) 10 (91%) X2 = 0.0, 1df 1.0
SSRI user 7 (64%) 6 (55%) X2 = 0.19, 1df 0.66
SRI (SSRI or SNRI) user 10 (91%) 8 (73%) X2 = 1.22, 1df 0.27
More than one antidepressant user 6 (55%) 6 (55%) X2 = 0.0, 1df 1.0
SMOKING STATUS
   Never 2 (18%) 4 (36%) X2 = 1.07, 2df 0.59
   Current 3 (27%) 3 (27%)
   Former 6 (55%) 4 (36%)

BMI, Body Mass Index; OEF/OIF, Operation Enduring Freedom / Operation Iraqi Freedom; PCL, PTSD Checklist; PHQ9, Patient Health Questionnaire 9; SSRI, Selective Serotonin Reuptake Inhibitor; SNRI, Serotonin and norepinephrine reuptake inhibitor; X2, Pearson's chi-squared test; t, Student's t-test.